TY  - GEN
AU  - Zeidner,Joshua F
AU  - Foster,Matthew C
AU  - Blackford,Amanda L
AU  - Litzow,Mark R
AU  - Morris,Lawrence E
AU  - Strickland,Stephen A
AU  - Lancet,Jeffrey E
AU  - Bose,Prithviraj
AU  - Levy,M Yair
AU  - Tibes,Raoul
AU  - Gojo,Ivana
AU  - Gocke,Christopher D
AU  - Rosner,Gary L
AU  - Little,Richard F
AU  - Wright,John J
AU  - Doyle,L Austin
AU  - Smith,B Douglas
AU  - Karp,Judith E
TI  - Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
SN  - 1592-8721
PY  - 2016///0321
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Female
KW  - Flavonoids
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Piperidines
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.3324/haematol.2015.125849
ER  -